PrecisionFDA Public Instance of GSRS
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- ODT Acquisition Liaison odtvendorexcellence@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring operations and maintenance services for the PrecisionFDA public instance of the Global Substance Registration System (GSRS), an enterprise platform serving as the authoritative system of record for substances and ingredients used in regulated drugs, biologics, foods, and medical devices. The contract will enable sponsors to securely share confidential substance and product information with the FDA in a private, virtual workspace. The solicitation is estimated to release on December 1, 2026, with award targeted for May 1, 2027.
The estimated award value ranges from $250,000 to $700,000. Interested vendors should contact the FDA's Office of Diagnostic & Technology Vendor Excellence mailbox at odtvendorexcellence@fda.hhs.gov for additional information.
Forecast text
IT Acquisition: The public FDA instance of GSRS was implemented on precisionFDA. This O&M contract enables this capability to allow Sponsors to securely share confidential substance and product information with the FDA in a private, virtual workspace. The Global Substance Registration System (GSRS) is a mission-critical FDA enterprise platform that serves as the authoritative system of record for substances and ingredients used in regulated drugs, biologics, foods, and medical devices.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast